Barclays’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26 Buy
+15
New +$20 ﹤0.01% 5276
2025
Q4
Sell
-3
Closed -$15 5586
2025
Q3
$15 Buy
+3
New +$16 ﹤0.01% 5379
2023
Q3
Sell
-5
Closed -$13 4682
2023
Q2
$13 Hold
5
﹤0.01% 4478
2023
Q1
$15 Hold
5
﹤0.01% 5031
2022
Q4
$19 Hold
5
﹤0.01% 5231
2022
Q3
$0 Hold
5
﹤0.01% 5061
2022
Q2
$0 Hold
5
﹤0.01% 5210
2022
Q1
$0 Hold
5
﹤0.01% 5479
2021
Q4
$0 Buy
+5
New +$68 ﹤0.01% 4617
2019
Q3
Hold
0
7044
2019
Q2
Sell
-36
Closed -$783 7198
2019
Q1
$1K Buy
+36
New +$1.21K ﹤0.01% 6924
2018
Q2
Sell
-72
Closed -$7K 7218
2018
Q1
$7K Buy
+72
New +$20.7K ﹤0.01% 6731
2016
Q2
Hold
0
6580
2016
Q1
Hold
0
6381

Other funds holding PULM

Barclays's PULM Position: Q2 2026 in Review

Barclays opened a new position in Pulmatrix (PULM) in Q2 2026: 15 shares worth $26. The stake represents ﹤0.01% of the portfolio and ranks #5276 among its holdings. This is a return to the name: Barclays previously reported a position in PULM as recently as Q3 2025.

Barclays first reported a position in PULM in Q1 2018 and has held it in 11 quarters since. The position peaked at $7K in Q1 2018. 15 funds tracked by Wall St. Rank hold PULM as of Q2 2026.

  • Barclays held 15 shares of Pulmatrix worth $26 as of Q2 2026.
  • Pulmatrix was a new Barclays position in Q2 2026.
  • Pulmatrix made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5276 holding.
  • Barclays first reported a position in Pulmatrix in Q1 2018 and has held it in 11 quarters since.
  • Barclays's Pulmatrix position peaked at $7K in Q1 2018.
  • 15 funds tracked by Wall St. Rank held Pulmatrix as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.